Alzheimer’s Studies and Trials
Welcome to the ATRI Clinical Trials and Studies page.
Here’s how to get started:
- Find an actively enrolling study
Browse our list of open trials below to see what’s currently recruiting participants. Each listing shows the Studies’ title, a brief overview, and enrollment status. - Learn more about any Study
Click on a Study of interest to view full details—including eligibility criteria, Study procedures, and time commitment—so you can determine if it’s right for you. - Enroll directly with the study team
Ready to join? If actively enrolling, click Actively Enrolling on the Study listing to be taken to that Studies’ website, where you can complete their secure registration and enrollment process.
If you have questions at any point—or don’t see a study that fits your needs—reach out to us directly. Fill out our contact form or give us a call at (858) 964-4644. We’re here to help you every step of the way.
Reset Filter
Actively Enrolling
50-85, Clinical Trial, Memory Impairement
Synaptic Therapy Alzheimer’s Research Trial
This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s disease. The START Study is a nationwide clinical trial and…
Actively Enrolling
40+, Clinical Trial, Memory Impairement
Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)
Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the end of their life. Of these, over seventy percent will…
Active – Fully Enrolled
50-90, Memory Impairement, Normal Memory, Observational - In Person
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a landmark study that began in 2004, is a public-private research partnership tasked with identifying biomarkers to detect Alzheimer’s disease (AD). The study has…